Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07393672 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Hemp-Derived Cannabinoids on Menopause Symptoms

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2, 2026 to Feb 11, 2026
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Trial Details
NCT Number NCT07393672
Lead Sponsor Washington State University
Collaborators: Terra Mater Botanicals Pty Ltd
Conditions
(from sponsor)		 Menopause, Perimenopause
Related terms Anxiety Disorders, Mental Fatigue, Pain
Enrollment 104 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov